ScoutCam is described as a developer of direct-visualization technology and minimally invasive tools. The company is a wholly-owned subsidiary of Medigus and is the subject of a pending securities exchange agreement with Intellisense Solutions Inc. Under the agreement ScoutCam would become a wholly-owned subsidiary of Intellisense in exchange for 60% of Intellisense’s issued and outstanding share capital. Intellisense announced it has secured commitments for a $3.5 million investment in ScoutCam at a $10 million pre-money valuation. The exchange closing is conditioned on Intellisense securing at least $3.0 million and is still subject to further closing conditions. There is an additional contingent issuance: if ScoutCam achieves $33 million in aggregate sales within three years of closing, Intellisense will issue Medigus an additional 10% of its issued and outstanding share capital.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2019